Andrew Callos Cytokinetics Inc (CYTK) insider trading activity
Andrew Callos is EVP, Chief Commercial Officer of CYTOKINETICS INC. Currently has a direct ownership of 65,712 shares of CYTK, which is worth approximately $3.28 Million. The most recent transaction as insider was on Dec 03, 2024, when has been sold 1,351 shares (Common Stock) at a price of $51.51 per share, resulting in proceeds of $69,590. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
65.7K
2.86%
3M change
22.41%
12M change
Total Value Held
$3.28 Million
Andrew Callos Transaction History
AC
Andrew Callos
EVP, Chief Commercial Officer
South San Francisco, CA